Axel Schörling
Chief Executive Officer presso EQL PHARMA AB
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Axel Schörling is currently the President & Chief Executive Officer at EQL Pharma AB since 2022 and the Director at Gasporox AB since 2023.
Previously, he worked as the Director-Business Controlling at Perstorp AB.
Mr. Schörling holds a graduate degree from Chalmers University of Technology and Handelshögskolan i Göteborg.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EQL PHARMA AB
0.88% | 31/03/2023 | 257 113 ( 0.88% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Axel Schörling
| Società | Posizione | Inizio |
|---|---|---|
| EQL PHARMA AB | Chief Executive Officer | 17/08/2022 |
| GASPOROX AB | Director/Board Member | 01/01/2023 |
Precedenti posizioni note di Axel Schörling
| Società | Posizione | Fine |
|---|---|---|
| PERSTORP HOLDING AB (PUBL.) | Corporate Officer/Principal | - |
Formazione di Axel Schörling
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GASPOROX AB | Commercial Services |
| EQL PHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
Perstorp AB
 Perstorp AB Chemicals: SpecialtyProcess Industries Perstorp AB manufactures and supplies specialty chemicals. The company was founded in 1881 and is headquartered in Perstorp, Sweden. | Process Industries |
- Borsa valori
- Insiders
- Axel Schörling
